Impact of Molybdenum Compounds as Anticancer Agents

الملخص EN

The aim of this mini review was to report the molybdenum compound intervention to control cancer disease.

The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies.

Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers).

Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.